28 May 2019 : Case report
Unusual clinical course, Mistake in diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Adverse events of drug therapy , Educational Purpose (only if useful for a systematic review or synthesis)Vassilis Voudris1BE, Panagiota Georgiadou1E*, Panagiotis Kalogris2B, Theodora Kostelidou3D, Andreas Karabinis4D, Grigorios Gerotziafas56D
Am J Case Rep 2019; 20:753-757
BACKGROUND: Heparin-induced thrombocytopenia (HIT) is a serious complication of heparin therapy, characterized by thrombocytopenia and high risk for venous and arterial thrombosis.
CASE REPORT: We report an unusual case of acute stent thrombosis secondary to delayed HIT. A 74-year-old man with non-ST-segment elevation myocardial infarction had a coronary angiography which revealed 2-vessel disease. A bolus of unfractionated heparin (UFH) was administered at admission and he received fondaparinux during his hospitalization. We performed elective percutaneous coronary intervention (PCI) with stents to LAD and LCx. Two hours after PCI, the patient developed acute pulmonary edema, and repeat angiography revealed an occlusive thrombus in the ostial LAD and the LCx. A turbidimetric assay for the rapid detection of plasma anti-PF4/heparin antibodies was negative. After repeated unsuccessful attempts of balloon angioplasty and continuous thrombosis, the patient was transferred for emergency surgical revascularisation and was treated with additional UFH followed by enoxaparin. Platelets decreased gradually to 38 k/μl 7 days after surgery, at which time enoxaparin was replaced with fondaparinux. The subsequent HIT test results were positive.
CONCLUSIONS: HIT should be considered in patients with multiple recent exposures to anticoagulants, independent of the platelet count, if there are signs and symptoms of thrombosis.
Keywords: Coronary Thrombosis, Heparin, Myocardial Infarction, Thrombocytopenia, Aged, Anticoagulants, Coronary Artery Disease, enoxaparin, percutaneous coronary intervention, Stents, Thrombosis
01 October 2023 : EditorialEditorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution
Med Sci Monit 2023; 29:e942672
04 Oct 2023 : Clinical ResearchA Retrospective Study of 205 Patients with Complex Kidney Stones to Compare Outcomes from Super-Mini Percut...
Med Sci Monit In Press; DOI: 10.12659/MSM.941012
03 Oct 2023 : Clinical ResearchPrevalence and Risk Factors for Modic Changes in Symptomatic Cervical Ossification of the Posterior Longitu...
Med Sci Monit In Press; DOI: 10.12659/MSM.941674
03 Oct 2023 : Clinical ResearchTime-Dependent Factors Influencing Cardiocerebral Vascular Events in Chronic Hemodialysis Patients: Insight...
Med Sci Monit In Press; DOI: 10.12659/MSM.941553
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
14 Dec 2022 : Clinical ResearchPrevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels
Med Sci Monit 2022; 28:e937990
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292